Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Update

Harvard Bioscience, Inc. (NASDAQ:HBIO) was the recipient of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 398,900 shares, a growth of 13.8% from the October 15th total of 350,600 shares. Based on an average daily volume of 116,700 shares, the short-interest ratio is currently 3.4 days.

Harvard Bioscience Price Performance

Shares of HBIO stock traded up $0.10 during trading hours on Monday, hitting $2.24. 31,639 shares of the company’s stock were exchanged, compared to its average volume of 116,807. The stock’s 50-day moving average is $2.52 and its 200-day moving average is $2.89. Harvard Bioscience has a 52 week low of $2.12 and a 52 week high of $5.56. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.06 and a quick ratio of 0.94. The stock has a market cap of $97.70 million, a price-to-earnings ratio of -6.67 and a beta of 1.31.

Institutional Investors Weigh In On Harvard Bioscience

A number of institutional investors and hedge funds have recently modified their holdings of the business. GSA Capital Partners LLP bought a new position in shares of Harvard Bioscience during the third quarter worth $30,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Harvard Bioscience in the second quarter valued at about $31,000. SG Americas Securities LLC acquired a new stake in shares of Harvard Bioscience in the 3rd quarter valued at approximately $36,000. Avior Wealth Management LLC increased its holdings in Harvard Bioscience by 1,118.1% during the third quarter. Avior Wealth Management LLC now owns 14,569 shares of the medical instruments supplier’s stock worth $39,000 after buying an additional 13,373 shares during the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new position in shares of Harvard Bioscience during the 2nd quarter worth about $40,000. 80.87% of the stock is owned by institutional investors.

About Harvard Bioscience

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.